Global Pharmaceutical Asset Management Industry Research Report 2020, Forecast to 2025

August 2020 | 103 pages | ID: G1252218908BEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Pharmaceutical Asset Management market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Pharmaceutical Asset Management is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Pharmaceutical Asset Management industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pharmaceutical Asset Management by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Pharmaceutical Asset Management market are discussed.

The market is segmented by types:

• Hardware (Pharma Asset)
• Software (Pharma Asset)

It can be also divided by applications:

• Anti-drug Counterfeiting
• Supply Chain Management

And this report covers the historical situation, present status and the future prospects of the global Pharmaceutical Asset Management market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• McKesson Corporation
• GE Healthcare
• Cerner Corporation
• IBM Corporation
• Siemens Healthcare
• Epic System
• Allscripts

Report Includes:

• xx data tables and xx additional tables
• An overview of global Pharmaceutical Asset Management market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Pharmaceutical Asset Management market
• Profiles of major players in the industry, including McKesson Corporation, GE Healthcare, Cerner Corporation, IBM Corporation, Siemens Healthcare.....

Research Objectives

• To study and analyze the global Pharmaceutical Asset Management consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Pharmaceutical Asset Management market by identifying its various subsegments.
• Focuses on the key global Pharmaceutical Asset Management manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Pharmaceutical Asset Management with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Pharmaceutical Asset Management submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Pharmaceutical Asset Management Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Pharmaceutical Asset Management Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 PHARMACEUTICAL ASSET MANAGEMENT INDUSTRY OVERVIEW

2.1 Global Pharmaceutical Asset Management Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Pharmaceutical Asset Management Global Import Market Analysis
  2.1.2 Pharmaceutical Asset Management Global Export Market Analysis
  2.1.3 Pharmaceutical Asset Management Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Hardware (Pharma Asset)
  2.2.2 Software (Pharma Asset)
2.3 Market Analysis by Application
  2.3.1 Anti-drug Counterfeiting
  2.3.2 Supply Chain Management
2.4 Global Pharmaceutical Asset Management Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Pharmaceutical Asset Management Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Pharmaceutical Asset Management Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Pharmaceutical Asset Management Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Pharmaceutical Asset Management Manufacturer Market Share
  2.4.5 Top 10 Pharmaceutical Asset Management Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Pharmaceutical Asset Management Market
  2.4.7 Key Manufacturers Pharmaceutical Asset Management Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Pharmaceutical Asset Management Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Asset Management Industry Impact
  2.7.1 How the Covid-19 is Affecting the Pharmaceutical Asset Management Industry
  2.7.2 Pharmaceutical Asset Management Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Pharmaceutical Asset Management Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Pharmaceutical Asset Management Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL PHARMACEUTICAL ASSET MANAGEMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Pharmaceutical Asset Management Sales Market Share by Region
4.2 Global Pharmaceutical Asset Management Revenue Market Share by Region (2015-2019)
4.3 Global Pharmaceutical Asset Management Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Pharmaceutical Asset Management Market Size Detail
  4.4.1 North America Pharmaceutical Asset Management Sales Growth Rate (2015-2020)
  4.4.2 North America Pharmaceutical Asset Management Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Pharmaceutical Asset Management Market Size Detail
  4.5.1 Europe Pharmaceutical Asset Management Sales Growth Rate (2015-2020)
  4.5.2 Europe Pharmaceutical Asset Management Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Pharmaceutical Asset Management Market Size Detail
  4.6.1 Japan Pharmaceutical Asset Management Sales Growth Rate (2015-2020)
  4.6.2 Japan Pharmaceutical Asset Management Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Pharmaceutical Asset Management Market Size Detail
  4.7.1 China Pharmaceutical Asset Management Sales Growth Rate (2015-2020)
  4.7.2 China Pharmaceutical Asset Management Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL PHARMACEUTICAL ASSET MANAGEMENT MARKET SEGMENT BY TYPE

5.1 Global Pharmaceutical Asset Management Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Pharmaceutical Asset Management Sales and Market Share by Type (2015-2020)
  5.1.2 Global Pharmaceutical Asset Management Revenue and Market Share by Type (2015-2020)
5.2 Hardware (Pharma Asset) Sales Growth Rate and Price
  5.2.1 Global Hardware (Pharma Asset) Sales Growth Rate (2015-2020)
  5.2.2 Global Hardware (Pharma Asset) Price (2015-2020)
5.3 Software (Pharma Asset) Sales Growth Rate and Price
  5.3.1 Global Software (Pharma Asset) Sales Growth Rate (2015-2020)
  5.3.2 Global Software (Pharma Asset) Price (2015-2020)

6 GLOBAL PHARMACEUTICAL ASSET MANAGEMENT MARKET SEGMENT BY APPLICATION

6.1 Global Pharmaceutical Asset ManagementSales Market Share by Application (2015-2020)
6.2 Anti-drug Counterfeiting Sales Growth Rate (2015-2020)
6.3 Supply Chain Management Sales Growth Rate (2015-2020)

7 GLOBAL PHARMACEUTICAL ASSET MANAGEMENT MARKET FORECAST

7.1 Global Pharmaceutical Asset Management Sales, Revenue Forecast
  7.1.1 Global Pharmaceutical Asset Management Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Pharmaceutical Asset Management Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Pharmaceutical Asset Management Price and Trend Forecast (2020-2025)
7.2 Global Pharmaceutical Asset Management Sales Forecast by Region (2020-2025)
  7.2.1 North America Pharmaceutical Asset Management Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Pharmaceutical Asset Management Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Pharmaceutical Asset Management Production, Revenue Forecast (2020-2025)
  7.2.4 China Pharmaceutical Asset Management Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF PHARMACEUTICAL ASSET MANAGEMENT INDUSTRY KEY MANUFACTURERS

8.1 McKesson Corporation
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 McKesson Corporation Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 McKesson Corporation News
8.2 GE Healthcare
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 GE Healthcare Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 GE Healthcare News
8.3 Cerner Corporation
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Cerner Corporation Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Cerner Corporation News
8.4 IBM Corporation
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 IBM Corporation Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 IBM Corporation News
8.5 Siemens Healthcare
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Siemens Healthcare Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Siemens Healthcare News
8.6 Epic System
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Epic System Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Epic System News
8.7 Allscripts
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Allscripts Pharmaceutical Asset Management Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Allscripts News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Pharmaceutical Asset Management Picture
Figure Research Programs/Design for This Report
Figure Global Pharmaceutical Asset Management Market by Regions (2019)
Table Global Market Pharmaceutical Asset Management Comparison by Regions (M USD) 2019-2025
Table Global Pharmaceutical Asset Management Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Pharmaceutical Asset Management by Type in 2019
Figure Hardware (Pharma Asset) Picture
Figure Software (Pharma Asset) Picture
Table Global Pharmaceutical Asset Management Sales by Application (2019-2025)
Figure Global Pharmaceutical Asset Management Sales Market Share by Application in 2019
Figure Anti-drug Counterfeiting Picture
Figure Supply Chain Management Picture
Table Global Pharmaceutical Asset Management Sales by Manufacturer (2018-2020)
Figure Global Pharmaceutical Asset Management Sales Market Share by Manufacturer in 2019
Table Global Pharmaceutical Asset Management Revenue by Manufacturer (2018-2020)
Figure Global Pharmaceutical Asset Management Revenue Market Share by Manufacturer in 2019
Table Global Pharmaceutical Asset Management Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pharmaceutical Asset Management Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Pharmaceutical Asset Management Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Pharmaceutical Asset Management Market
Table Key Manufacturers Pharmaceutical Asset Management Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharmaceutical Asset Management
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Pharmaceutical Asset Management Sales (K Units) by Region (2015-2020)
Table Global Pharmaceutical Asset Management Sales Market Share by Region (2015-2019)
Figure Global Pharmaceutical Asset Management Sales Market Share by Region (2015-2019)
Figure Global Pharmaceutical Asset Management Sales Market Share by Region in 2018
Table Global Pharmaceutical Asset Management Revenue (Million US$) by Region (2015-2020)
Table Global Pharmaceutical Asset Management Revenue Market Share by Region (2015-2020)
Figure Global Pharmaceutical Asset Management Revenue Market Share by Region (2015-2020)
Figure Global Pharmaceutical Asset Management Revenue Market Share by Region in 2019
Table Global Pharmaceutical Asset Management Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Pharmaceutical Asset Management Sales (K Units) Growth Rate (2015-2020)
Table North America Pharmaceutical Asset Management Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Pharmaceutical Asset Management Sales (K Units) Growth Rate (2015-2020)
Table Europe Pharmaceutical Asset Management Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Pharmaceutical Asset Management Sales (K Units) Growth Rate (2015-2020)
Table Japan Pharmaceutical Asset Management Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Pharmaceutical Asset Management Sales (K Units) Growth Rate (2015-2020)
Table China Pharmaceutical Asset Management Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Pharmaceutical Asset Management Sales by Type (2015-2020)
Table Global Pharmaceutical Asset Management Sales Market Share by Type (2015-2020)
Figure Global Pharmaceutical Asset Management Sales Market Share by Type in 2019
Table Global Pharmaceutical Asset Management Revenue by Type (2015-2020)
Table Global Pharmaceutical Asset Management Revenue Market Share by Type (2015-2020)
Figure Global Pharmaceutical Asset Management Revenue Market Share by Type in 2019
Figure Global Hardware (Pharma Asset) Sales Growth Rate (2015-2020)
Figure Global Hardware (Pharma Asset) Price (2015-2020)
Figure Global Software (Pharma Asset) Sales Growth Rate (2015-2020)
Figure Global Software (Pharma Asset) Price (2015-2020)
Table Global Pharmaceutical Asset Management Sales by Application (2015-2020)
Table Global Pharmaceutical Asset Management Sales Market Share by Application (2015-2020)
Figure Global Pharmaceutical Asset Management Sales Market Share by Application in 2019
Figure Global Anti-drug Counterfeiting Sales Growth Rate (2015-2020)
Figure Global Supply Chain Management Sales Growth Rate (2015-2020)
Figure Global Pharmaceutical Asset Management Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Pharmaceutical Asset Management Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Pharmaceutical Asset Management Price and Trend Forecast (2020-2025)
Table Global Pharmaceutical Asset Management Sales (K Units) Forecast by Region (2020-2025)
Figure Global Pharmaceutical Asset Management Production Market Share Forecast by Region (2020-2025)
Figure North America Pharmaceutical Asset Management Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Pharmaceutical Asset Management Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Pharmaceutical Asset Management Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Pharmaceutical Asset Management Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Pharmaceutical Asset Management Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Pharmaceutical Asset Management Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Pharmaceutical Asset Management Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Pharmaceutical Asset Management Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table McKesson Corporation Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of McKesson Corporation
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure McKesson Corporation Pharmaceutical Asset Management Market Share (2018-2020)
Table McKesson Corporation Main Business
Table McKesson Corporation Recent Development
Table GE Healthcare Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of GE Healthcare
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure GE Healthcare Pharmaceutical Asset Management Market Share (2018-2020)
Table GE Healthcare Main Business
Table GE Healthcare Recent Development
Table Cerner Corporation Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of Cerner Corporation
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cerner Corporation Pharmaceutical Asset Management Market Share (2018-2020)
Table Cerner Corporation Main Business
Table Cerner Corporation Recent Development
Table IBM Corporation Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of IBM Corporation
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure IBM Corporation Pharmaceutical Asset Management Market Share (2018-2020)
Table IBM Corporation Main Business
Table IBM Corporation Recent Development
Table Siemens Healthcare Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of Siemens Healthcare
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure Siemens Healthcare Pharmaceutical Asset Management Market Share (2018-2020)
Table Siemens Healthcare Main Business
Table Siemens Healthcare Recent Development
Table Epic System Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of Epic System
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure Epic System Pharmaceutical Asset Management Market Share (2018-2020)
Table Epic System Main Business
Table Epic System Recent Development
Table Allscripts Company Profile
Figure Pharmaceutical Asset Management Product Picture and Specifications of Allscripts
Table Pharmaceutical Asset Management Production, Price, Revenue and Gross Margin of 2018-2020
Figure Allscripts Pharmaceutical Asset Management Market Share (2018-2020)
Table Allscripts Main Business
Table Allscripts Recent Development
Table of Appendix